Company intelligence / Profile preview

Shmuel Gonen Technologies Ltd.

Ownership: Private
Development stage: Commercial

Overview

A clinical trial (NCT03652701) for Hair Up was withdrawn. The study aimed to assess the performance of Hair Up on female pattern hair shedding and regrowth with 58 adult female patients[1].

Therapeutic areas: Dermatology
Modalities: Natural preparations
Industry: Biotech

Drug pipeline

1 asset

Hair Up

Commercial

Indications: Alopecia areata, Alopecia totalis, Alopecia universalis, Androgenic alopecia, Seborrheic dermatitis

Beyond the preview

Go deeper on Shmuel Gonen Technologies Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shmuel Gonen Technologies Ltd..

Explore the full profile